Chronic hepatitis B
Do you want to receive a message when there is new research about Chronic hepatitis B? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence that explains what was investigated — and you receive a message as soon as there is new research about Chronic hepatitis B. View what Premium costs.
Publications (1405)
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Severe digital ischemia coexists with thrombocytopenia in malignancy-associated antiphospholipid syndrome: A case report and review of literature. (2021/12/26) ♡
- Big Data Information under Proportional Hazard Mathematical Model in Analysis of Hepatitis B Virus Infection Data of Patients with Interventional Liver Cancer through Antiviral Therapy of Entecavir. (2021/12/23) ♡
- Deep Learning in the Classification of Stage of Liver Fibrosis in Chronic Hepatitis B with Magnetic Resonance ADC Images. (2021/12/22) ♡
- Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy. (2021/12/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas. (2021/12/21) ♡
- Phase 3 studyiResearch in a large group of patients, the final step before a treatment can be approved. What comes out here carries significant weight. Switching from entecavir to tenofovir disoproxil fumarate for HBeAg-positive chronic hepatitis B patients: a phase 4, prospective study. (2021/12/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis. (2021/12/20) ♡
- [Research status and challenges of low-level viremia in chronic hepatitis B]. (2021/12/20) ♡
- [Clinical significance and management strategies of low-level viremia during the treatment of chronic hepatitis B]. (2021/12/20) ♡
- [Low-level viremia-induced liver fibrosis and hepatocellular carcinoma in chronic hepatitis B]. (2021/12/20) ♡
- [Very low-level viremia: new clinical attention-requiring problem during the course of anti-hepatitis B virus treatment]. (2021/12/20) ♡
- [A possible mechanism for low-level viremia occurrence in nucleos(t)ide analog-treated chronic hepatitis B patients]. (2021/12/20) ♡
- [Expression and diagnostic value of macrophage inflammatory protein-3α in patients with hepatitis B-related acute-on-chronic liver failure]. (2021/12/20) ♡
- [Should chronic HBV infection patients with persistently normal transaminase be treated?]. (2021/12/20) ♡
- [Serum ALT is incapable to act as an essential prerequisite for initiating antiviral therapy in patients with chronic HBV infection]. (2021/12/20) ♡
- [Evaluation and suggestions for ALT threshold to initiate antiviral therapy in patients with chronic hepatitis B virus infection]. (2021/12/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Antiviral therapy and clinical cure for chronic hepatitis B in children: progress and challenges]. (2021/12/20) ♡
- De novo and relapsing necrotizing vasculitis after COVID-19 vaccination. (2021/12/20) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Recurrent pulmonary cryptococcosis during chronic HBV infection: A case report. (2021/12/17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review. (2021/12/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel Therapies of Hepatitis B and D. (2021/12/17) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intrahepatic Biliary Cystadenoma With Colonic Adenomatous Polyps in a Patient With Chronic Hepatitis B: A Case Report and Literature Review. (2021/12/16) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Development and validation of the nomogram based on INR and eGFR for estimation of mortality in patients with acute-on-chronic hepatitis B liver failure. (2021/12/15) ♡
- Changes in the clinical characteristics of chronic hepatitis B patients at the initiation of treatment over a 15-year period. (2021/12/14) ♡
- Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules. (2021/12/11) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Dengue-Induced Hemophagocytic Lymphohistiocytosis: A Case Report and Literature Review. (2021/12/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Severe Guillain-Barré syndrome associated with chronic hepatitis B: A case report and literature review. (2021/12/03) ♡
- Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population. (2021/12/02) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cytokines and Chemokines in HBV Infection. (2021/12/02) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. HBV RNA, Hepatitis B Core-Related Antigen, and Quantitative Hepatitis B Surface Antigen Biomarkers to Predict Outcome of Antiviral Therapy. (2021/12/01) ♡
- Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B. (2021/12/01) ♡
- Impact of switching to tenofovir alafenamide fumarate in patients with entecavir-treated chronic hepatitis B. (2021/12/01) ♡
- ANTXR1 as a potential prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma identified by a weighted gene correlation network analysis. (2021/12/01) ♡
- Concurrence and impact of hepatic steatosis on chronic hepatitis B patients: a systematic review and meta-analysis. (2021/12/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans. (2021/11/30) ♡
- Analytical Performance of the Sysmex HISCL HBsAg Assay and Comparison with the Roche Elecsys HBsAg II Quant Assay in the Quantification of Hepatitis B Surface Antigen. (2021/11/29) ♡
- Retracted publicationiThis research has been withdrawn by science itself, for example due to a flaw in the method or unreliable data. Do not use it as support and do not discuss it as evidence. Long-Term Carbohydrate-Containing Late-Evening Snack Significantly Improves the Ratio of Branched Chain Amino Acids to Aromatic Amino Acids in Adults with Liver Cirrhosis due to Hepatitis B. (2021/11/22) ♡
- Cancer Evo-Dev: A Theory of Inflammation-Induced Oncogenesis. (2021/11/22) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. [Study of the inhibitory effect of cell entry inhibitory ezetimibe on hepatitis B virus in vitro]. (2021/11/20) ♡
- [Abnormal expression of CD44 aggravates liver disease progression in patients with non-alcoholic fatty liver disease accompanied with hepatitis B virus replication]. (2021/11/20) ♡
- [ALT threshold individualized assessment for antiviral therapy initiation in chronic hepatitis B]. (2021/11/20) ♡
- [Should the threshold of alanine aminotransferase for initiating antiviral treatment of chronic hepatitis B be revised?]. (2021/11/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV. (2021/11/19) ♡
- MiR-571 affects the development and progression of liver fibrosis by regulating the Notch3 pathway. (2021/11/08) ♡
- The role of explanatory models of chronic hepatitis B on illness experience: a qualitative study of Vietnamese participants in Australia. (2021/11/01) ♡
- Prevalence of HBV Infection, Vaccine-Induced Immunity, and Susceptibility Among At-Risk Populations: US Households, 2013-2018. (2021/11/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America. (2021/11/01) ♡
- Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study. (2021/11/01) ♡
- Prevalence of hepatitis E infection among adults with concurrent chronic liver disease. (2021/11/01) ♡
- Dynamic monitoring with shear wave elastography predicts outcomes of chronic hepatitis B patients with decompensated cirrhosis. (2021/11/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.